Related Experiment Videos
[Multi-modality therapy concept in metastatic follicular thyroid carcinoma with hyperthyroidism]
M Brauckhoff1, K Dorsch, J Hädecke
1Klinik für Allgemeinchirurgie, Martin-Luther-Universität Halle-Wittenberg.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|February 28, 2001
Summary
This case study highlights a rare instance of hyperthyroidism co-occurring with thyroid cancer. Effective treatment involved surgery and radioiodine therapy for metastatic follicular thyroid cancer, leading to a euthyroid state.
Area of Science:
- Endocrinology
- Oncology
- Nuclear Medicine
Background:
- Hyperthyroidism and thyroid carcinoma rarely coincide.
- Functionally active metastases of thyroid carcinoma are infrequently reported.
- Toxic nodular goiter can mask or coexist with thyroid malignancy.
Observation:
- A 59-year-old male presented with toxic nodular goiter, later diagnosed with follicular thyroid carcinoma post-surgery.
- Following thyroidectomy and lymphadenectomy, the patient developed severe hyperthyroidism.
- Scintigraphy revealed significant radioiodine uptake in a sacral metastasis.
Findings:
- Surgical debulking of the sacral metastasis followed by high-dose radioiodine treatment was successful.
- Post-treatment, the patient achieved a euthyroid state, indicating effective management of both cancer and hyperthyroidism.
- This case demonstrates the potential for thyroid cancer metastases to retain functional activity.
Implications:
- Multimodal therapeutic strategies are essential for managing hyperthyroidism in metastatic thyroid cancer.
- Radioiodine therapy can be effective for functional thyroid cancer metastases.
- This case underscores the importance of thorough histological examination even in cases of presumed benign thyroid conditions.